Je was op zoek naar: proprietary (Fins - Engels)

company proprietary
company proprietary

valmistajakohtainen sovellustunnisteen tarkennin (proprietary application identifier extension)
proprietary application identifier extension

inn yhteisen kansainvälisen nimistön mukainen nimi (international non-proprietary name)
inn international non-proprietary name

[kaupankäynti omaan lukuun] hsh lopettaa dedicated proprietary trading -toiminnan.
[trading for own account] hsh is to end dedicated proprietary trading.

innm yhteisen kansainvälisen muutetun nimistön mukainen nimi (international non-proprietary name modified)
innm international non-proprietary name modified

[kaupankäynti omaan lukuun] Övag ei harjoita edelleenkään dedicated proprietary trading -toimintaa.
[trade for own account] Övag is to further refrain from conducting dedicated proprietary trading.

tämä lyhenne tarkoittaa maailman terveysjärjestön suosittelemaa kansainvälistä nimeä (international non-proprietary name).
this abbreviation refers to the international non-proprietary name recommended by the world health organisation.

puheensiirtoa internetissä koskeva suljetut ja standardit protokollat (voice over internet proprietary and standard protocol, voip).
interception equipment for voip proprietary and standard protocol

yrityksillä saattaa kärsiä, erityisesti tiedotusvälineiden jättiläiset, jotka ovat tehneet miljardien pois proprietary media, mutta taiteilijat voivat yhä ansaita elantonsa.
corporations might suffer, especially the media giants who have been making billions off proprietary media, but artists will still be able to make a living。

committee for proprietary medicinal products (cpmp), final eu recommendations for the influenza vaccine composition for the season 2002/ 2003
committee for proprietary medicinal products (cpmp), final eu recommendations for the influenza vaccine composition for the season 2002/2003

the non-proprietary names (inn) for pharmaceutical products -luettelo, maailman terveysjärjestö who, geneve, elokuu 1975.
the non-proprietary names (inn) for pharmaceutical products, who, geneva, august 1975.

risk assessment in relation to bovine spongiform encephalopathies (bse) note for guidance on the use of bovine serum in the manufacture of human biological medicinal products concept paper on the development of a cpmp note for guidance on requirements for the evaluation of new adjuvants in vaccines testing for sv40 in polio virus vaccines cpmp position statement on the quality of water used in the production of vaccines for parenteral use points to consider on quality aspects of medicinal products containing active substances produced by stable transgene experession in higher plants committee for proprietary medicinal products (cpmp) , final eu recommendations for the influenza vaccine composition for the season 2002/2003 public report on risk and regulatory assessment of lactose and other products prepared using calfrennet cpmp position statement on non-remunerated and remunerated donors:
risk assessment in relation to bovine spongiform encephalopathies (bse) concept paper on the development of a cpmp note for guidance on requirements for the evaluation of new adjuvants in vaccines testing for sv40 in polio virus vaccines cpmp position statement on the quality of water used in the production of vaccines for parenteral use committee for proprietary medicinal products (cpmp) , final eu recommendations for the influenza vaccine composition for the season 2002/2003 public report on risk and regulatory assessment of lactose and other products prepared using calfrennet cpmp position statement on non-remunerated and remunerated donors: